Adult Allergy and Immunology, Hamad Medical Corporation, Doha, Qatar was established in 2010 and serves adults with allergic and immunodeficiency diseases with the highest quality of care to patients with the utmost compassion through effective leadership, the promotion of excellence, and ongoing education and research.
The service currently includes
Specialized clinics: focuses on general allergies, severe Asthma, Urticaria/ angioedema, drug and food allergies, and immunodeficiency diseases. Also, we founded clinical pharmacy (PCP) and allergy biologics review clinics.
Allergy Lab: operates various diagnostic and therapeutic procedures, including skin prick test, skin patch test, oral food challenge, drug challenge, and desensitization.
Infusion and medication administration service: takes care of immunoglobulin administration (intravenous or subcutaneous) for patients with immunodeficiencies as daycare service, with two monitored beds, subcutaneous and sublingual immunotherapy, and administration of different biologics.
Research Lab: actively involves clinical and translational researches with multiple grants from the Medical Research Center (MRC)-HMC and Qatar National Research Foundation (QNRF). The ongoing research includes projects to identify pollen and fungal spore patterns and their impact on health and establishes Qatar pollen calendar, studies to identify various biomarkers in asthma, urticaria, primary immunodeficiency, and others.
The Allergy and Immunology Section runs a well-structured 3-year Combined (pediatric and adult) Allergy and Immunology Fellowship Program with an intake of 2 fellows per year. The program received ACGME-International accreditation in 2018. It offers excellent training with a didactic educational program.
The service is actively involved in patient education and collaborates with various patient groups. Patient awareness is conducted through the HMC web portal and the wider media.
Multiple accreditations have been received, including World Allergy Organization (WAO) Centers of Excellence (WCOE) since 2020, Urticaria Center of Reference and Excellence (UCARE) since 2018, and Angioedema Center of Reference and Excellence (ACARE) since 2020 by the Global Allergy and Asthma European Network (GA²LEN).
Maryam Al-Nesf, MD, ABHS, MScR
Head of Allergy and Immunology Section, HMC, Qatar